# Sanofi (SNY)

Source page: https://stoqly.net/companies/sny

- **Ticker:** SNY (Nasdaq)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001121404
- **Latest annual report:** 20-F filed 2026-02-17 (https://www.sec.gov/Archives/edgar/data/1121404/000162828026008403/sny-20251231.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $44.34 on 2026-10-30
- **Market cap:** $108.7B
- **P/E (trailing):** 12.3x
- **EPS, trailing 12 months:** $3.59
- **Return on invested capital:** 5.8%
- **Return on equity:** 10.7%
- **Net debt:** $13.0B
- **Change in share count:** −2.4%
- **Piotroski F-score:** 5/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/sny/figures.csv

| US$ millions | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Operating income | 7,223 | 6,543 | 5,518 | 3,415 | 16,086 | 9,610 | 10,680 | 7,527 | 7,845 | 7,154 |
| Net income | 5,208 | 9,488 | 5,081 | 3,083 | 14,013 | 7,360 | 8,798 | 5,840 | 6,015 | 8,810 |
| Diluted EPS (US$) | 2.01 | 3.74 | 2.02 | 1.25 | 5.57 | 2.93 | 3.50 | 2.33 | 2.40 | 3.59 |
| Operating cash flow | 8,668 | 8,319 | 6,545 | 8,636 | 8,455 | 12,444 | 11,063 | 11,093 | 9,824 | 12,122 |
| Cash | 10,829 | 12,371 | 7,929 | 10,590 | 17,075 | 11,437 | 13,584 | 9,625 | 7,730 | 8,997 |
| Debt and leases | 19,510 | 18,551 | 28,151 | 27,600 | 27,771 | 22,935 | 20,498 | 18,267 | 16,765 | 21,975 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.